End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
67.6 TWD | +1.81% | +4.00% | +4.32% |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- With a P/E ratio at 10.87 for the current year and 10.18 for next year, earnings multiples are highly attractive compared with competitors.
- The company appears to be poorly valued given its net asset value.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's enterprise value to sales, at 3.9 times its current sales, is high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.32% | 26.97B | A | ||
+3.05% | 95.15B | B | ||
+1.78% | 94.71B | B- | ||
-20.65% | 77.24B | B+ | ||
+18.68% | 74.93B | D+ | ||
+6.69% | 30.04B | B | ||
+18.06% | 27.87B | B | ||
-1.21% | 16.99B | C+ | ||
-9.10% | 15.16B | B | ||
+20.70% | 12.62B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 2881 Stock
- Ratings Fubon Financial Holding Co., Ltd.